Retraction Note: Effect of atorvastatin on pulmonary arterial hypertension in rats through PI3K/AKT signaling pathway
Y.-Y. Wang, X.-D. Cheng, H. Jiang Neonatal Intensive Care Unit, Affiliated Hospital of Jining Medical College, Jining, China
The article “Effect of atorvastatin on pulmonary arterial hypertension in rats through PI3K/AKT signaling pathway”, by Y.-Y. Wang, X.-D. Cheng, H. Jiang, published in Eur Rev Med Pharmacol Sci 2019; 23 (23): 10549-10556–DOI: 10.26355/eurrev_201912_19696–PMID: 31841211 has been retracted by the Authors.
After publication, issues were raised on PubPeer about the reliability of the published results, in particular, of Figures 2 and 3. The authors stated that the article presents some inaccuracies as the data cannot be repeated by further research.
This article has been retracted. The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadEffect of atorvastatin on pulmonary arterial hypertension in rats through PI3K/AKT signaling pathway
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
Y.-Y. Wang, X.-D. Cheng, H. Jiang
Retraction Note: Effect of atorvastatin on pulmonary arterial hypertension in rats through PI3K/AKT signaling pathway
Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 17
Pages: 7881-7881
DOI: 10.26355/eurrev_202309_33543